Hot off the press! Just last month, in December 2018, results from a clinical trial for a potential new treatment for patients with a blinding inherited eye disease were published in Nature Medicine.
This trial, which studied the effect of an intravitreal injection for patients with Leber congenital amaurosis (LCA) due to mutations in the CEP290 gene, showed promising results, and I was invited to join the popular “Straight From the Cutter’s Mouth: A Retina Podcast” this week to discuss the results. If you’d like to listen to the podcast, it is available at the link above, or directly via the stream below, or on iTunes. I come in around the 12:55 mark, but you should definitely listen to Dr. Ho first, one of the paper’s authors.
Between these results, and those that led to the development of a commercially-available treatment for another type of LCA, the future is bright for patients with inherited retinal disease!